The Global TissueEngineering Market, by Material Type (Synthetic, Biological, and Others),by Application (Dermal, Orthopedic, Dental, Neurology, and Others), and byRegion (North America, Latin America, Europe, Asia Pacific, Middle East, andAfrica) was valued at US$ 5.5 billion in 2017, and is projected to exhibit aCAGR of 11.5% over the forecast period (2018 - 2026).
Various diseases, injury, andtrauma can lead to degeneration and damage of tissues in the human body, whichnecessitates treatments to enable repair, replacement or regeneration ofdamaged tissue. The treatment normally focuses on transplanting tissue from onesite to another in the same patient (an autograft) or from one individual toanother (a transplant or allograft). Tissue engineering is aninter-disciplinarily research area, which has wider applications in repair oforgans, regeneration, and tissue transplantation. The technology uses syntheticor naturally derived, engineered biomaterials to replace defective or damagedtissues, such as bone, skin, and organs. Key manufacturers in the tissueengineering market are focused on mergers and acquisitions, and partnershipswith smaller companies.
* The sample copy includes:Report Summary, Table of Contents, Segmentation, Competitive Landscape, ReportStructure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2217
For instance, in 2017, FUJIFILMCorporation invested US$ 3.7 million in the regenerative medicine venturecompany NC Medical Research, Inc. with NC Medical granting Fujifilm a stockallocation. Rapid advances in stem cell research with a focus on therapeuticpotential for regenerative medicine and other biomedical applications areexpected to drive market growth. In combination with tissue engineering, stemcells exhibit growth opportunities in further advancing modern medicine.Although much progress has been made in the field of tissue engineering, furtherresearch regarding organ and tissue replacement is necessary. The optimal cellsource, scaffold design, and in vitro bioreactors, the use and development ofmicrofabrication technology to create vascularized tissues and organs are stillbeing investigated.
Browse 21 Market Data Tables and24 Figures spread through 175 Pages and in-depth TOC on "TissueEngineering Market, by Material Type (Synthetic, Biological and Others), byApplication (Dermal, Orthopedic, Dental, Neurology, and Others), and by Region(North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -Global Forecast to 2026"
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/tissue-engineering-market-2217
Key Takeaways of the TissueEngineering Market:
The global tissue engineeringmarket is expected to expand at a CAGR of 11.5% during the forecast period(2018–2026), owing to increasing demand for organ transplantation.
Among region, Europe is expectedto grow at lucrative rate, owing to presence of various public and privateorganizations focusing on research in tissue engineering field.
Major players operating in theglobal tissue engineering market include Acelity L.P. Inc., Allergan Plc.,Athersys, Inc., B. Braun, BioMimetic Therapeutics, Bio Tissue Technologies, C.R. Bard, International Stem Cell, Integra Lifesciences, Medtronic, Inc.,Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., StrykerCorporation, Tissue Regenix Group Plc., and Zimmer Biomet.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2217
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
